Therefore, immune checkpoint inhibitors may be an option for the treatment of recurrent and drug-resistant GTN.<h4>Case</h4>Four patients with recurrent or drug-resistant GTN who were treated with PD-1/PD-L1 checkpoint inhibitor agents combined with chemotherapy were reported. This evidence concerns the gene PDCD1 and gestational trophoblastic neoplasm.